These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 1747644
1. Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. Patchett S, Beattie S, Leen E, Keane C, O'Morain C. BMJ; 1991 Nov 16; 303(6812):1238-40. PubMed ID: 1747644 [Abstract] [Full Text] [Related]
2. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. Park KN, Hahm JS, Kim HJ. Eur J Gastroenterol Hepatol; 1994 Dec 16; 6 Suppl 1():S103-7. PubMed ID: 7735924 [Abstract] [Full Text] [Related]
3. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out. Bojarski C, Epple HJ, Kirstein FW, Fromm M, Bisson S, Riecken EO, Schulzke JD. Z Gastroenterol; 2000 Mar 16; 38(3):211-9. PubMed ID: 10768243 [Abstract] [Full Text] [Related]
4. Helicobacter pylori gastritis and non-ulcer dyspepsia in childhood. Efficacy of one-week triple antimicrobial therapy in eradicating the organism. Cucchiara S, Salvia G, Az-Zeqeh N, D'Armiento FD, De Petra MR, Rapagiolo S, Campanozzi A, Emiliano M. Ital J Gastroenterol; 1996 Mar 16; 28(8):430-5. PubMed ID: 9032584 [Abstract] [Full Text] [Related]
5. Long-term follow-up of Helicobacter pylori treatment in non-ulcer dyspepsia patients. Elta GH, Scheiman JM, Barnett JL, Nostrant TT, Behler EM, Crause I, Appelman HD. Am J Gastroenterol; 1995 Jul 16; 90(7):1089-93. PubMed ID: 7611203 [Abstract] [Full Text] [Related]
6. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection. Lara LF, Cisneros G, Gurney M, Van Ness M, Jarjoura D, Moauro B, Polen A, Rutecki G, Whittier F. Arch Intern Med; 2003 Sep 22; 163(17):2079-84. PubMed ID: 14504122 [Abstract] [Full Text] [Related]
7. Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia. Vaira D, Holton J, Ainley C, Falzon M, Osborn J, D'Anna L, Romanos A, Chandrakumaran K, McNeil I. Ital J Gastroenterol; 1992 Sep 22; 24(7):400-4. PubMed ID: 1392023 [Abstract] [Full Text] [Related]
8. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial. Kung NN, Sung JJ, Yuen NW, Li TH, Ng PW, Lai WM, Lui YH, Lam KN, Choi CH, Leung EM. Am J Gastroenterol; 1999 Mar 22; 94(3):721-4. PubMed ID: 10086657 [Abstract] [Full Text] [Related]
9. Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection. Tucci A, Poli L, Gasperoni S, Varoli O, Paparo GF, De Giorgio R, Stanghellini V, Corinaldesi R. Ital J Gastroenterol; 1994 Apr 22; 26(3):107-10. PubMed ID: 8061335 [Abstract] [Full Text] [Related]
10. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection. Zheng Q, Pan Y, Zhang L, Xiao SD. Chin J Dig Dis; 2005 Apr 22; 6(4):202-5. PubMed ID: 16246231 [Abstract] [Full Text] [Related]
11. Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study. Lazzaroni M, Bargiggia S, Sangaletti O, Maconi G, Boldorini M, Bianchi Porro G. Dig Dis Sci; 1996 Aug 22; 41(8):1589-94. PubMed ID: 8769284 [Abstract] [Full Text] [Related]
12. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study. Labenz J, Gyenes E, Rühl GH, Börsch G. Gut; 1993 Sep 22; 34(9):1167-70. PubMed ID: 8406147 [Abstract] [Full Text] [Related]
13. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial. Bago J, Halle ZB, Strinić D, Kućisec N, Jandrić D, Bevanda M, Tomić M, Bilić A. Wien Klin Wochenschr; 2002 Jun 28; 114(12):448-53. PubMed ID: 12422579 [Abstract] [Full Text] [Related]
14. Colloidal bismuth subcitrate in non-ulcer dyspepsia. Khanna MU, Abraham P, Nair NG, Mistry FP, Vora IM. J Postgrad Med; 1992 Jun 28; 38(3):106-8. PubMed ID: 1303406 [Abstract] [Full Text] [Related]
15. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens. Xia HX, Gilvarry J, Beattie S, Hamilton H, Keane CT, Sweeney EC, O'Morain CA. Am J Gastroenterol; 1995 Aug 28; 90(8):1221-5. PubMed ID: 7639218 [Abstract] [Full Text] [Related]
17. Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Thijs JC, Van Zwet AA, Oey HB. Scand J Gastroenterol; 1993 Nov 28; 28(11):934-8. PubMed ID: 8284626 [Abstract] [Full Text] [Related]
18. Bismuth-based therapies for the first step eradication of Helicobacter pylori. Sezgin O, Altintaş E, Uçbilek E, Tataroğlu C. Turk J Gastroenterol; 2006 Jun 28; 17(2):90-3. PubMed ID: 16830288 [Abstract] [Full Text] [Related]
19. Role of anti-Helicobacter pylori treatment in H. pylori-positive and cytoprotective drugs in H. pylori-negative, non-ulcer dyspepsia: results of a randomized, double-blind, controlled trial in Asian Indians. Dhali GK, Garg PK, Sharma MP. J Gastroenterol Hepatol; 1999 Jun 28; 14(6):523-8. PubMed ID: 10385059 [Abstract] [Full Text] [Related]
20. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy. Kung NN, Sung JJ, Yuen NW, Ng PW, Wong KC, Chung EC, Lim BH, Choi CH, Li TH, Ma HC, Kwok SP. Am J Gastroenterol; 1997 Mar 28; 92(3):438-41. PubMed ID: 9068464 [Abstract] [Full Text] [Related] Page: [Next] [New Search]